Arnold Gelb With Quest Dx to Talk at Molecular Diagnostics Conference, Mar 7-8 2011, Philadelphia
Arnold Gelb with Quest Dx to talk at Molecular Diagnostics Conference, Mar 7-8 2011, Philadelphia
Daniel Edelman With NCI,set to Talk at Molecular Diagnostics Conference, Mar 7-8 2011, Philadelphia
Daniel Edelman, Facility Head of the Clinical Molecular Profiling Core at NCI, will give a presentation on “The Clinical Molecular Profiling Core: A New Paradigm in Personalized Cancer Care at the National Cancer Institute”. In this new age of targeted and personalized therapies, oncologists have become acutely aware that each patient and their associated tumor have their own characteristic biological properties; matching the correct treatment to the right patient and tumor appears increasingly important.
Bruce Schneider, General Medicine Team Leader at CDER/FDA to Speak at Diabetes Summit, March 8, 2011
Bruce Schneider, General Medicine Team Leader at CDER/FDA to speak at Diabetes Summit, March 8, 2011
John E. Sims, Executive Director at Amgen to Speak at 9th Cytokines Conference Jan 27, 2011 in Cali
John E. Sims, Scientific Executive Director at Amgen will give a featured presentation on “IL-36 Cytokines and Psoriasis” at the at 9th Cytokines & Inflammation Conference to be held in San Diego, CA on January 27-28, 2011 by GTCbio.
Jeremy Barton of Biogen Idec to Speak at Cancer Drugs Conference on Jan 2011 CA
Jeremy Barton, VP of Oncology at Biogen Idec will be the keynote presenter on “Targeted Drug Delivery: How Far from the Bulls Eye?” at GTCbio’s Cancer Drugs Research & Development Conference on January 27-28, 2011 in San Diego, CA
Rep. Henry Waxman, D-CA, to Give Keynote Speech, Healthcare Conference Washington, DC Nov. 8-9, 2010
Rep. Henry Waxman, D-CA, will give a keynote presentation discussing the legislative implications of healthcare reform at GTCbio’s upcoming conference Healthcare Reform: Dealing with Hurdles and Building Up Successes, on Nov. 8-9, 2010 in Washington, DC.
John Heissenbuttel, Co-Director at Council on Sustainable Biomass Production and President at Phoenix Strategic Solutions to Give Presentation at Future of Bio-Based Chemicals: From Inception to Marketplace Conference (Sept 13-14) in San Francisco
John Heissenbuttel, Co-Director at Council on Sustainable Biomass Production and President at Phoenix Strategic Solutions to speak at GTCbio’s Future of Bio-Based Chemicals: From Inception to Marketplace conference on September 13-14, 2010.
Irena Steele at Memorial Sloan-Kettering to Speak at 5th Assay Conference Sept 20-21, 2010 San Diego
Irena Steele, Senior Research Scientist, at Memorial Sloan-Kettering Cancer Center, will give a presentation on “A High content screening approach for the ABCG2 transporter: Merits of live cell assays.” at 5th Assay and Drug Discovery Technologies Conference to be held this year in San Diego, CA Sept. 20-21, 2010 by GTCbio.
Daniel G. Sipes at Novartis / GNF to Speak at 5th Assay Conference Sept. 20-21, 2010 San Diego
This conference provides a venue for professionals in the drug discovery industry and academics to get an update of exciting new developments in assay technologies and exchange ideas in developing creative approaches in the drug discovery and development process to improve the efficiency and output.
Pacific Biosciences to Speak at 5th Assay Conference Sept 20-21, 2010 San Diego
Stephen Turner, Founder & Chief Technology Officer of Pacific Biosciences to speak at GTCbio’s 5th Assay and Drug Discovery Technologies on Sept. 20-21, 2010 in San Diego, CA.